Laddar...
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
Type 2 diabetes has become a major burden to the health care systems worldwide. Among the drugs approved for this indication, glimepiride and rosiglitazone have gained substantial importance in routine use. While glimepiride stimulates β-cell secretion and leads to reduction of blood glucose values,...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1994031/ https://ncbi.nlm.nih.gov/pubmed/17580731 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|